FDA protecting you again, except cancer is okay as long as a big pharma like Merck is the one selling carcinogen-contaminated drugs.

Quote:

---

The FDA said Tuesday that it recently became aware of a nitrosamine impurity, Nitroso-STG-19 or NTTP, in certain samples of Merck’s type 2 diabetes drug Januvia.

To avoid a shortage of the drug that pulled in more than $10.5 billion for Merck in 2020 and 2021, and to help ensure patients have access to an adequate supply, the FDA said it will not object to the temporary distribution of sitagliptin containing the impurity above the acceptable intake limit.

Typically, if a drug contains levels of nitrosamines above the acceptable daily intake limit, the FDA recommends the manufacturer conduct a recall.

https://endpts.com/to-avoid-shortage-of-merck...mporarily/

---

But by all means, keep asking for more safety data for drugs like Leronlimab. Keep looking for side effects until you manage to find some.